LVV-Hemorphin-7 Peptide
LVV-Hemorphin-7 Peptide
Product description
Hemorphin-7 binds to the angiotensin IV receptor (AT4R), triggering multiple effects including cellular proliferation and memory enhancement. VV-hemorphins and LVV-hemorphins preferentially interact with delta and kappa receptors. LVV-hemorphin-7 potentiates the activity of bradykinin, causing a decrease in blood pressure. Hemorphins are endogenous peptides belonging to the family of atypical opioid peptides released from hydrolyzed hemoglobin.
| Appearance | N/A |
|---|---|
| Molecular weight | N/A |
| Purity | >90% |
| Solubility | N/A |
| Synonyms | Hemorphin-7; LVV-hemorphin-7; Hemoglobin subunit beta; beta-globin; hemoglobin beta chain |
| Sequence | H-Leu-Val-Val-Tyr-Pro-Trp-Thr-Gln-Arg-Phe-OH or H-LVVYPWTQRF-OH |
| Molecular Formula | C65H93N15O14 |
| Storage | -20℃,protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds of LVV-Hemorphin-7 Peptide
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


